SNY News and Press, Sanofi From 02/26/26

2026-02-26 13:35:52 ET More on leading drugmakers Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie Johnson & Johnson: Strong Run May Be Ending (Rating Downgrade) Merck: Why Investors Should Remain Bullish Despite Patent Risks ...

2026-02-26 09:07:15 ET More on Novavax Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? Here's Why Pfizer Is Willing To Pay $500 Million For Novavax's Matrix-M Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conf...

2026-02-25 07:19:21 ET More on Pfizer, Merck, etc. Merck: Why Investors Should Remain Bullish Despite Patent Risks Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) ...

2026-02-24 12:06:38 ET More on Pfizer, Merck, etc. Merck: Why Investors Should Remain Bullish Despite Patent Risks Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) ...

2026-02-24 10:32:21 ET More on Regeneron Pharmaceuticals Regeneron: Expect Double-Digit Growth In 2026 Regeneron Pharmaceuticals, Inc. (REGN) Q4 2025 Earnings Call Transcript Regeneron Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation Regen...

2026-02-23 22:35:52 ET Company Background Electromed ( ELMD ) is a small medical device company based in Minnesota. It was founded in 1992 by Robert D. Hansen and Craig N. Hansen, and it IPO’d in 2010 at $4 a share. Shareholders did pretty poorly in the first 9 years ...

2026-02-23 13:42:29 ET Denver, Colorado - Shares of Kraig Biocraft Laboratories (OTCQB:KBLB) are likely to attract additional attention, as Kraig’s recombinant spider silk technology is featured on the cover of the March 2026 issue of National Geographic. The publication spot...

2026-02-22 08:00:00 ET In my last article, "Merck: Wall Street Surprised By Q3 Strength, Keytruda Sales Surge" , I have been talking mainly about Merck's (MRK) Q3 results and the efficacy of Keytruda+Pfizer’s (PFE) Padcev in the KEYNOTE-905.... Read the full article on ...

2026-02-20 15:21:00 ET More on pharmaceutical companies Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) Eli Lilly Trumps Novo Nordisk In GLP-1 Race: Multi-Year Growth Prospects Pfizer: Recovery Isn't Over, Battered Valuation St...

2026-02-20 07:41:55 ET More on Sanofi Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi replaces CEO Paul Hudson, names ...